Alaska Children's EYE & Strabismus
Anchorage, Alaska, 99508, United States
Location status: Recruiting
Location contact
Brion Beerle, MD
CONTACT
Robert W Arnold, MD
CONTACT
Robert W Arnold, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04353960
Observation study monitoring vital signs and anesthetic variables particularly heart rate during prospective, ocular manipulation and specifically uniform tension on extra ocular muscles during strabismus surgery.
*IRB approval from 1992 covered in letter from then IRB chair Dr. Judith Whitcomb, Anchorage, Alaska (letter 10/2020).*
Interested in participating?
Request Info1 month–100 year
All sexes
Observational
Anchorage, Alaska, 99508, United States
Location status: Recruiting
Brion Beerle, MD
CONTACT
Robert W Arnold, MD
CONTACT
Robert W Arnold, MD
PRINCIPAL_INVESTIGATOR
Patients with ocular manipulation including those scheduled for strabismus surgery will have peri-operative variables monitored before, during and after uniform traction on extra ocular muscles (EOM). The oculocardiac reflex (OCR) will be elicited by quantified (200 gram, 10-second, square-wave) traction on Jameson muscle hook under insertion of an extra ocular muscle (EOM, rectus). Stable pre-tension heart rate, and greatest change heart rate will be recorded. Additional variables to be recorded: birthdate, gender, race, weight, iris color, pre-operative neurodevelopmental conditions, pre-operative medications, induction medications, expired carbon dioxide (CO2) levels, exhaled gas concentrations, anticholinergic medications, opioids, muscle relaxants, type of airway and the number of EOM operated.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
electrocardiograph monitor during strabismus surgery
Other names: ECG, EKG
Time frame: 30 seconds
Continuous variable of percent change in heart rate from stable pre-heart rate to greatest change heart rate during strabismus surgery
Time frame: 2 hours
Impact of existing and emerging anesthetics on oculocardiac reflex. This shall include various existing and emerging medications and inhalation agents, dosage, routes, airway types, general anesthesia and awake, and monitor methods.
Time frame: 2 hours
The impact of various patient characteristics on oculocardiac reflex including patient age, weight, gender and race, the presence of neuro-developmental condition.
Time frame: 2 hours
The impact of various aspects/phases of ocular manipulation and/or surgical technique. This includes monitored electrocardiograph during insertion of lid speculum, pressure on the globe, grasping of conjunctiva, incision of conjunctiva, dissection of Tenon's capsule, traction on extra ocular muscle, suturing extra ocular muscle, disinsertion of extra ocular muscle, re-suturing of extra ocular muscle and closure of conjunctiva.
Contact information is provided by the study sponsor or research team.
Brion J Beerle, MD
CONTACT
Robert W Arnold, MD
CONTACT
Alaska Blind Child Discovery
Other
Acronym: AK-OCR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03663413
Arrhythmias, Cardiac, Bradycardia
View Trial DetailsNCT03672435
Arrhythmias, Cardiac, Bradycardia
View Trial DetailsNCT07118358
AV Block, Arrhythmias, Cardiac
Ypsilanti, Michigan, United States
View Trial DetailsNCT05815745
Arrhythmias, Cardiac, Bradycardia
Dublin, Ireland
View Trial Details